
|Podcasts|December 6, 2021
The Changing Landscape of Clinical Research Sites With Frenova Renal Research
Author(s)Frenova Renal Research®
Kurt Mussina, MBA, president of Frenova Renal Research, explains how the site landscape is changing for clinical research. He has years of experience leading a global network of investigators, patients and data scientists involved in clinical studies. He brings a unique perspective to what the major problems in clinical research sites are, including private equity and industry consolidation. Refreshingly, he provides solutions Frenova is implementing that will promote better clinical research sites.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
2
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
3
Applying Systems Thinking to the Future of Clinical R&D
4
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
5



